{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:52:37Z","timestamp":1790805157147,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sylphar, University of Witten\/Herdecke"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Herpes simplex labialis (HSL) is a viral disease that affects the perioral region. No guidelines recommending an effective treatment exist. The treatment of HSL with three different products was examined. Herpatch Serum, a film-forming patch, was compared to Compeed Patches, a set of semiocclusive hydrocolloid patches, and Zovirax Cream (ingredient: 5% acyclovir). In this prospective, randomized, examiner-blind study, 180 patients with recurrent HSL were split into three groups (Compeed: <jats:italic>n<\/jats:italic>\u2009=\u200960, Herpatch: <jats:italic>n<\/jats:italic>\u2009=\u200960, Zovirax: <jats:italic>n<\/jats:italic>\u2009=\u200960) and examined within 24\u2009hours of HSL outbreak (DRKS Registration No.: DRKS00007786). The primary endpoint was healing time. The secondary endpoints were the reaction rate and quality of therapy evaluated by the Clinician\u2019s Global Assessment of Therapy (CGAT) and the Subject\u2019s Global Assessment of Therapy (SGAT) (0\u2009=\u2009no response; 10 = excellent response), respectively. There was no significant difference among the healing times for the different products. The mean (95% confidence interval) was 9.67 days (9.11\u201310.22) for Compeed, 9.30 days (8.75\u20139.85) for Herpatch, and 9.80 days (9.30\u201310.30) for Zovirax. The reaction rate and quality of therapy (CGAT and SGAT) of Herpatch were significantly higher than those of Compeed and Zovirax. Within the study limitations, Herpatch proved to be an effective, non-antiviral alternative in the treatment of HSL.<\/jats:p>","DOI":"10.1038\/s41598-020-63530-6","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:03:27Z","timestamp":1586945007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Study on the Effectiveness of Three Products in the Treatment of Herpes Simplex Labialis"],"prefix":"10.1038","volume":"10","author":[{"given":"Hanna","family":"Boes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlasios","family":"Goulioumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6697-2548","authenticated-orcid":false,"given":"Stefan","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Bizhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"63530_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2527-1","volume":"17","author":"G Korr","year":"2017","unstructured":"Korr, G. et al. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infect. Dis. 17, 471 (2017).","journal-title":"BMC Infect. Dis."},{"key":"63530_CR2","doi-asserted-by":"crossref","unstructured":"Darai, G., Handermann, M., Sonntag, H. G., Tidona, C. & Z\u00f6ller, L. In Lexikon der Infektionskrankheiten des Menschen (Third Edition) (ed. Gholamreza Darai) 388\u201391 (Springer, 2009).","DOI":"10.1007\/978-3-540-39026-8"},{"key":"63530_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0714.2011.01037.x","volume":"41","author":"S Skulason","year":"2012","unstructured":"Skulason, S., Holbrook, W. P., Thormar, H., Gunnarsson, G. B. & Kristmundsdottir, T. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis. J. Oral. Pathol. Med. 41, 61\u201367 (2012).","journal-title":"J. Oral. Pathol. Med."},{"key":"63530_CR4","first-page":"107","volume":"37","author":"PG Arduino","year":"2008","unstructured":"Arduino, P. G. & Porter, S. R. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. J. Am. Acad. Dermatol. 37, 107\u2013121 (2008).","journal-title":"J. Am. Acad. Dermatol."},{"key":"63530_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.emc.2018.09.006","volume":"37","author":"S Diebold","year":"2019","unstructured":"Diebold, S. & Overbeck, M. Soft Tissue Disorders of the Mouth. Emerg. Med. Clin. N. Am. 37, 55\u201368 (2019).","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"63530_CR6","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1111\/j.1468-3083.2011.04348.x","volume":"26","author":"B Dreno","year":"2012","unstructured":"Dreno, B., Malkin, J. E., Saiag, P. & Batuji-Garin, S. Patient\u00b4s profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France. J. Eur. Acad. Dermatol. 26, 1458\u20131460 (2012).","journal-title":"J. Eur. Acad. Dermatol."},{"key":"63530_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1708-8240.2011.00417.x","volume":"24","author":"JP McCarthy","year":"2012","unstructured":"McCarthy, J. P., Browning, W. D., Teerlink, C. & Veit, G. Treatment of herpes labialis: comparison of two OTC drugs and untreated controls. J. Esthet. Restor. Dent. 24, 103\u2013109 (2012).","journal-title":"J. Esthet. Restor. Dent."},{"key":"63530_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1708-8240.2011.00469.x","volume":"24","author":"WD Browning","year":"2012","unstructured":"Browning, W. D. & McCarthy, J. P. A case series: herpes simplex virus as an occupational hazard. J. Esthet. Restor. Dent. 24, 61\u201366 (2012).","journal-title":"J. Esthet. Restor. Dent."},{"key":"63530_CR9","first-page":"498","volume":"69","author":"GW Raborn","year":"2003","unstructured":"Raborn, G. W. & Grace, M. G. Recurrent herpes simplex labialis: selected therapeutic options. J. Can. Dent. Assoc. 69, 498\u2013503 (2003).","journal-title":"J. Can. Dent. Assoc."},{"key":"63530_CR10","unstructured":"Tubridy, E., Kelsberg, G. & St. Anna, L. Clinical Inquiry: which drugs are most effective for recurrent herpes labialis?. J. Fam. Pract. 63, 104\u2013105 (2014)."},{"key":"63530_CR11","first-page":"139","volume":"59","author":"J Patora","year":"2002","unstructured":"Patora, J. & Klimek, B. Flavonoids from lemon balm (Melissa officinalis L., Lamiaceae). Acta Pol. Pharm. 59, 139\u2013143 (2002).","journal-title":"Acta Pol. Pharm."},{"key":"63530_CR12","first-page":"94","volume":"10","author":"NS Al-Waili","year":"2004","unstructured":"Al-Waili, N. S. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions. Med. Sci. Monit. 10, 94\u201398 (2004).","journal-title":"Med. Sci. Monit."},{"key":"63530_CR13","first-page":"729","volume":"9","author":"M Honarmand","year":"2017","unstructured":"Honarmand, M., Farhadmollashahi, L. & Vosoughirahbar, E. Comparing the effect of diode laser against acyclovir cream for the treatment of herpes labialis. J. Clin. Exp. Dent. 9, 729\u2013732 (2017).","journal-title":"J. Clin. Exp. Dent."},{"key":"63530_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1601-0825.2006.01202.x","volume":"12","author":"PG Arduino","year":"2006","unstructured":"Arduino, P. G. & Porter, S. R. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 12, 254\u2013270 (2006).","journal-title":"Oral Dis."},{"key":"63530_CR15","doi-asserted-by":"crossref","unstructured":"Lotufo, M. A. et al. \u201cEfficacy of photodynamic therapy on the treatment of herpes labialis: a systematic review\u201d. Photodiagnosis Photodyn. Ther. (2019).","DOI":"10.1016\/j.pdpdt.2019.08.018"},{"key":"63530_CR16","doi-asserted-by":"crossref","unstructured":"Zupin, L. et al. Antiviral properties of blue laser in an in vitro model of HSV-1 infection. Microbiol. Immunol. (2018).","DOI":"10.1111\/1348-0421.12600"},{"key":"63530_CR17","unstructured":"Glaxo Operations UK. ZOVIRAX Labialis, 50 mg\/g, Cr\u00e8me Aciclovir (Package Insert) (2012)."},{"key":"63530_CR18","unstructured":"U.S. Food and Drug Administration. ZOVIRAX (acyclovir) cream 5% for topical use - Reference ID: 3481551 (2014)."},{"key":"63530_CR19","unstructured":"Johnson & Johnson. Compeed Herpesbl\u00e4schen-Patch (Package Insert) (2011)."},{"key":"63530_CR20","unstructured":"Sylphar NV. Herpatch - herpes cold sore serum (Package Insert) (2017)."},{"key":"63530_CR21","unstructured":"Sylphar NV. Clinical Evaluation Report of the medical device Herpatch Serum (2017)."},{"key":"63530_CR22","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1468-3083.2008.02761.x","volume":"22","author":"T Karlsmark","year":"2008","unstructured":"Karlsmark, T., Goodman, J. J., Drouault, Y., Lufrano, L. & Pledger, G. W. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis. J. Eur. Acad. Dermatol. 22, 1184\u20131192 (2008).","journal-title":"J. Eur. Acad. Dermatol."},{"key":"63530_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul, F., Erdfelder, E., Buchner, A. & Lang, A. G. Statistiacal power analysis using G*Power 3.1: Test for correlation and regression analyses. Behav. Res. Methods 41, 1149\u20131160 (2009).","journal-title":"Behav. Res. Methods"},{"key":"63530_CR24","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/j.1468-3083.2007.02302.x","volume":"21","author":"D Malvy","year":"2007","unstructured":"Malvy, D. et al. Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study. J. Eur. Acad. Dermatol. 21, 1398\u20131403 (2007).","journal-title":"J. Eur. Acad. Dermatol."},{"key":"63530_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jmv.22233","volume":"84","author":"F Pica","year":"2012","unstructured":"Pica, F. & Volpi, A. Public awareness and knowledge of herpes labialis. J. Med. Virol. 84, 132\u2013137 (2012).","journal-title":"J. Med. Virol."},{"key":"63530_CR26","doi-asserted-by":"crossref","unstructured":"QuickStats. Age-Adjusted Trends in the Prevalence of Herpes Simplex Virus Type 1 (HSV-1) and Herpes Simplex Virus Type 2 (HSV-2) Among Adolescents and Adults Aged 14-49 Years - United States,1999-2000 Through 2015-2016. Morb. Mortal. Wkly Rep. 67, 203 (2018).","DOI":"10.15585\/mmwr.mm6706a7"},{"key":"63530_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jac\/12.suppl_B.89","volume":"12","author":"WA Van Vloten","year":"1983","unstructured":"Van Vloten, W. A., Swart, R. N. & Pot, F. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections. J. Antimicrob. Chemother. 12, 89\u201393 (1983).","journal-title":"J. Antimicrob. Chemother."},{"key":"63530_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10354-018-0667-6","volume":"169","author":"J Jautov\u00e1","year":"2019","unstructured":"Jautov\u00e1, J. et al. Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage): Randomized, controlled double-blind study. Wien. Med. Wochenschr. 169, 193\u2013201 (2019).","journal-title":"Wien. Med. Wochenschr."},{"key":"63530_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000349991","volume":"226","author":"G Senti","year":"2013","unstructured":"Senti, G. et al. A Randomized, Double-Blind, Placebo-Controlled Study to Test the Efficacy of Topical 2-Hydroxypropyl-Beta-Cyclodextrin in the Prophylaxis of Recurrent Herpes Labialis. Dermatology 226, 247\u2013252 (2013).","journal-title":"Dermatology"},{"key":"63530_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.14219\/jada.archive.2002.0169","volume":"133","author":"GW Raborn","year":"2002","unstructured":"Raborn, G. W. et al. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J. Am. Dent. Assoc. 133, 303\u2013309 (2002).","journal-title":"J. Am. Dent. Assoc."},{"key":"63530_CR31","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1128\/AAC.46.7.2238-2243.2002","volume":"46","author":"SL Spruance","year":"2002","unstructured":"Spruance, S. L. et al. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob. Agents Chemother. 46, 2238\u20132243 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"63530_CR32","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1128\/AAC.47.3.1072-1080.2003","volume":"47","author":"SL Spruance","year":"2003","unstructured":"Spruance, S. L. et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob. Agents Chemother. 47, 1072\u20131080 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"63530_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00105-005-1041-3","volume":"57","author":"G Gross","year":"2006","unstructured":"Gross, G. & Braun, D. Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis: Results of post-marketing surveillance. Hautarzt 57, 40\u201346 (2006).","journal-title":"Hautarzt"},{"key":"63530_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1067\/mjd.2001.116215","volume":"45","author":"SL Sacks","year":"2001","unstructured":"Sacks, S. L. et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J. Am. Acad. Dermatol. 45, 222\u2013230 (2001).","journal-title":"J. Am. Acad. Dermatol."},{"key":"63530_CR35","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1128\/AAC.46.6.1870-1874.2002","volume":"46","author":"TG Evans","year":"2002","unstructured":"Evans, T. G. et al. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob. Agents Chemother. 46, 1870\u20131874 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"63530_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1128\/AAC.25.5.553","volume":"25","author":"SL Spruance","year":"1984","unstructured":"Spruance, S. L. et al. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob. Agents Chemother. 25, 553\u2013555 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"63530_CR37","doi-asserted-by":"crossref","unstructured":"Semprini, A. et al. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial. BMJ Open 9 (2019).","DOI":"10.1136\/bmjopen-2018-026201"},{"key":"63530_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","volume":"57","author":"M Fatahzadeh","year":"2007","unstructured":"Fatahzadeh, M. & Schwartz, R. A. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J. Am. Acad. Dermatol. 57, 737\u2013763 (2007).","journal-title":"J. Am. Acad. Dermatol."},{"key":"63530_CR39","doi-asserted-by":"crossref","unstructured":"Doerr, H. W. & Gerlich, W. In Medizinische Virologie: Grundlagen, Diagnostik, Pr\u00e4vention und Therapie viraler Erkrankungen (Second Edition) (Hans W. Doerr) 17-43, 149-153, 653-660 (Thieme Verlag, 2010).","DOI":"10.1055\/b-001-2163"},{"key":"63530_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/infdis\/161.2.185","volume":"161","author":"SL Spruance","year":"1990","unstructured":"Spruance, S. L. et al. Treatment of recurrent herpes simplex labialis with oral acyclovir. J. Infec.t Dis. 161, 185\u2013190 (1990).","journal-title":"J. Infec.t Dis."},{"key":"63530_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/wound.2012.0412","volume":"2","author":"JPE Junker","year":"2013","unstructured":"Junker, J. P. E., Kamel, R. A., Caterson, E. J. & Eriksson, E. Clinical Impact Upon Wound Healing and Inflammation in Moist, Wet, and Dry Environments. Adv. Wound Care 2, 348\u2013356 (2013).","journal-title":"Adv. Wound Care"},{"key":"63530_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1515\/med-2015-0078","volume":"10","author":"L Wei","year":"2015","unstructured":"Wei, L. The application of moist dressing in treating burn wound. Open Med. 10, 452\u2013456 (2015).","journal-title":"Open Med."},{"key":"63530_CR43","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/j.1468-3083.2011.04269.x","volume":"26","author":"A Khemis","year":"2012","unstructured":"Khemis, A. et al. Evaluation of the efficacy and safety of a CS20(R) protective barrier gel containing OGT compared with topical aciclovir and placebo on functional and objective symptoms of labial herpes recurrences: a randomized clinical trial. J. Eur. Acad. Dermatol. 26, 1240\u20131246 (2012).","journal-title":"J. Eur. Acad. Dermatol."},{"key":"63530_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2017.10.004","volume":"88","author":"P Arenberger","year":"2018","unstructured":"Arenberger, P., Arenbergerova, M., Hladikova, M., Holcova, S. & Ottillinger, B. Comparative Study with a Lip Balm Containing 0.5% Propolis Special Extract GH 2002 versus 5% Aciclovir Cream in Patients with Herpes Labialis in the Papular\/Erythematous Stage: A Single-blind, Randomized, Two-arm Study. Curr. Ther. Res. Clin. E. 88, 1\u20137 (2018).","journal-title":"Curr. Ther. Res. Clin. E."},{"key":"63530_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.039","volume":"76","author":"W Tang","year":"2010","unstructured":"Tang, W. & Bhushan, B. Adhesion, friction and wear characterization of skin and skin cream using atomic force microscope. Colloids Surf. B 76, 1\u201315 (2010).","journal-title":"Colloids Surf. B"},{"key":"63530_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/09546630701593457","volume":"19","author":"I Zschocke","year":"2008","unstructured":"Zschocke, I., Reich, C., Zielke, A., Reitmeier, N. & Reich, K. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial. J. Dermatol. Treat. 19, 176\u2013181 (2008).","journal-title":"J. Dermatol. Treat."},{"key":"63530_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/jac\/48.3.450","volume":"48","author":"CF Carson","year":"2001","unstructured":"Carson, C. F., Ashton, L., Dry, L., Smith, D. W. & Riley, T. V. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J. Antimicrob. Chemother. 48, 450\u2013451 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"63530_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jop.12534","volume":"46","author":"F Chen","year":"2017","unstructured":"Chen, F. et al. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis. J. Oral Pathol. Med. 46, 561\u2013568 (2017).","journal-title":"J. Oral Pathol. Med."},{"key":"63530_CR49","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/odi.13234","volume":"25","author":"S Petti","year":"2019","unstructured":"Petti, S. & Lodi, G. The controversial natural history of oral herpes simplex virus type 1 infection. Oral Dis. 25, 1850\u20131865 (2019).","journal-title":"Oral Dis."},{"key":"63530_CR50","first-page":"7","volume":"291","author":"M Shaw","year":"1985","unstructured":"Shaw, M. et al. Failure of acyclovir cream in treatment of recurrent herpes labialis. BMJ Open 291, 7\u20139 (1985).","journal-title":"BMJ Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63530-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63530-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63530-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:40:22Z","timestamp":1670319622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63530-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63530"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63530-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6465"}}